The Bredesen Cognoscopy Panel: A Comprehensive Tool for Personalized Cognitive Health Assessment

The Bredesen Cognoscopy Alzheimer’s Panel is a series of tests to identify a reverse the risk of cognitive decline.

The cognoscopy Alzheimer’s panel evaluates patients unique biochemistry profile in order to narrow treatment focus on six key objectives: burning fat, addressing insulin sensitivity, optimizing health support, reducing inflammation, treating pathogens, and addressing toxin exposure. It also emphasizes the need to optimize sleep and rule out sleep disorders.

Watch video interviews with Bredesen on Second Opinion Physician website.